Radiologia Brasileira - Publicação Científica Oficial do Colégio Brasileiro de Radiologia

INTRODUCTION

Idiopathic interstitial pneumonias (IIPs) are part of a broad, heterogeneous group of interstitial lung diseases that encompasses more than 200 acute or chronic diseases with varying degrees of inflammation or fibrosis. Given the innumerable clinical, radiological, and pathological aspects, as well as the constant need to analyze the course of IIPs, it is essential that the diagnosis and follow-up of these diseases be conducted within a multidisciplinary scenario in which the radiologist assumes a fundamental role. High-resolution computed tomography of the chest has been the subject of recent publications in the radiology literature of Brazil^(1-7). The integrated approach notwithstanding, the final classification and definitive diagnosis might not be achieved in all cases. Some cases do not meet the criteria for classification into any of the classic interstitial lung disease categories and are therefore designated “unclassifiable”. Such cases continue to pose a challenge for the entire multidisciplinary team.

The most recent (2013) update of the American Thoracic Society/European Respiratory Society IIP classification^(8,9) proposes some important changes in relation to the original (2002) classification. Notable among those changes are the subdivision of IIPs into four main groups (chronic fibrosing, smoking-related, acute/subacute, and rare) and the addition of a new disease: idiopathic pleuroparenchymal fibroelastosis.

In this study, we provide a brief clinical description of each of these four IIP groups, as well as presenting their main radiological characteristics (Table 1), including tomographic findings and distribution patterns, together with the main differential diagnoses. The images presented were selected from the teaching files of our institution, from cases in which the tomographic pattern was typical of each IIP, with pathological confirmation.




CHRONIC FIBROSING IIPs

Idiopathic pulmonary fibrosis (Figure 1)




Among all IIPs⁽¹⁰⁾, idiopathic pulmonary fibrosis is the most common; it is an interstitial lung disease of unknown cause, characterized histologically by the usual interstitial pneumonia pattern^(11,12), with dispersed fibroblastic foci and heterogeneous involvement of the parenchyma, areas of tissue preservation being interspersed with areas of interstitial inflammation and honeycombing. It occurs mainly in adults over 50 years of age who are smokers or former smokers, typically manifesting as progressive dyspnea and dry cough. In general, it has a poor prognosis, with an estimated survival of less than five years after the diagnosis. Patients usually have fewer acute exacerbations when treated with cyclosporine combined with corticosteroids, and most are considered candidates for lung transplantation⁽¹⁰⁾. In an appropriate clinical setting (typical clinical and radiological findings), the diagnosis of idiopathic pulmonary fibrosis can be established without the need for biopsy⁽¹⁰⁾.

Nonspecific interstitial pneumonia (Figure 2)




Nonspecific interstitial pneumonia is characterized histologically by homogeneous inflammation and expansion of the alveolar walls, with or without fibrosis; it can be classified as belonging to one of three subtypes⁽¹¹⁾: cellular (less common and with a better prognosis); fibrotic (with a worse prognosis); or mixed. Nonspecific interstitial pneumonia can be idiopathic, although it most often manifests as pulmonary symptoms associated with connective tissue diseases (especially scleroderma), hypersensitivity pneumonia, drug reactions, or diffuse alveolar damage. It typically occurs in women between 40 and 50 years of age, with symptoms similar to, although usually milder than, those of idiopathic pulmonary fibrosis. Treatment is directed to the underlying disease and can include the use of a combination of systemic corticosteroids and cytotoxic drugs, which is successful in most cases⁽¹⁰⁾. Although the tomographic findings of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia are often similar⁽¹³⁾, an experienced radiologist knows the main differences between them (Table 1).


SMOKING-RELATED IIPs

Desquamative interstitial pneumonia (Figure 3)




Desquamative interstitial pneumonia is a rare disease that is strongly associated with smoking; in some cases, it progresses to respiratory failure and advanced pulmonary fibrosis⁽⁸⁾. Histopathological findings include homogeneous thickening of the alveolar septa and intra-alveolar accumulation of pigmented macrophages⁽¹¹⁾. Men between 30 and 50 years of age constitute the majority of patients; after smoking cessation and corticosteroid therapy, there is significant improvement of the symptoms⁽¹¹⁾.

Respiratory bronchiolitis-associated interstitial lung disease (Figure 4)




Classically characterized by the combination of interstitial disease and respiratory bronchiolitis, the typical histological findings of respiratory bronchiolitis-associated interstitial lung disease include the accumulation of pigmented macrophages in the respiratory bronchioles, alveolar ducts, and adjacent alveoli, together with minimal fibrosis and inflammatory infiltrate⁽¹¹⁾. The affected patients are usually men between 30 and 50 years of age who have few or no symptoms. The treatment consists of smoking cessation and corticosteroid therapy⁽¹⁰⁾.


ACUTE AND SUBACUTE IIPs

Cryptogenic organizing pneumonia (Figure 5)




Formerly known as bronchiolitis obliterans organizing pneumonia, organizing pneumonia is characterized histologically by buds of granulation tissue within the alveolar ducts and adjacent alveoli, accompanied by chronic inflammatory infiltrate involving the interstitium and alveolar spaces⁽⁸⁾. That is a common pattern of response to various types of lung injury and is most commonly found in conjunction with connective tissue diseases, drug-induced adverse pulmonary reactions, hypersensitivity pneumonia, infectious processes, and aspiration, among others. When no cause is identified, it is known as cryptogenic organization pneumonia⁽¹⁰⁾. It predominantly affects individuals between 50 and 70 years of age, with no gender preference; most patients seek treatment in one to three months after the symptom onset, which is often preceded by respiratory tract infections⁽¹¹⁾. Corticosteroid treatment usually produces an excellent response⁽⁹⁾.

Acute interstitial pneumonia (Figure 6)




Acute interstitial pneumonia is an extremely severe idiopathic acute interstitial disease, characterized by a histopathological pattern of diffuse alveolar damage, the exudative phase of which is defined by interstitial and intra-alveolar edema, formation of hyaline membranes, and diffuse alveolar infiltration of inflammatory cells. It has a poor prognosis (mortality greater than 50%), mainly affecting previously healthy patients between 50 and 60 years of age, with severe sudden-onset dyspnea (occurring within the first three weeks), typically progressing to the need for mechanical ventilation⁽¹⁰⁾. The clinical, radiological, and histological findings are the same as those of acute respiratory distress syndrome⁽¹¹⁾. The treatment is basically supportive, with oxygen supplementation, and the use of corticosteroids is effective in the acute phase⁽¹⁰⁾.

RARE IIPs

Lymphocytic interstitial pneumonia (Figure 7)




In the vast majority of patients, lymphocytic interstitial pneumonia is associated with systemic autoimmune or immunodeficiency disorders, including connective tissue diseases (mainly Sjögren''s syndrome, autoimmune thyroiditis, and primary biliary cirrhosis). In its idiopathic form, it is considered extremely rare. Histologically, it is characterized by diffuse infiltration of the interstitium by polyclonal lymphocytes, histiocytes, and variable numbers of plasma cells, as well as reactive lymphoid follicles distributed throughout the peribronchovascular regions, accompanied by intense inflammation⁽¹¹⁾. It mainly affects women between 50 and 70 years of age, with nonspecific symptoms of chronic coughing and dyspnea (typically for more than three years). The response to corticosteroid therapy is unpredictable⁽¹⁰⁾.

Idiopathic pleuroparenchymal fibroelastosis (Figure 8)




Idiopathic pleuroparenchymal fibroelastosis is a rare disease affecting the pleura and lungs. It is characterized histologically by homogeneous subpleural fibrosis and abundant elastic fibers, with variable inflammation and lymphoid aggregates. Currently, there is no consensus regarding its diagnostic criteria or regarding the fact that it is a new entity⁽¹⁴⁾. With a little more than 40 cases described in the literature to date, this entity has been associated with infections, bone marrow transplantation, autoimmune diseases, and genetic predisposition. Its symptoms are nonspecific (dry cough and dyspnea), and it is believed to progress slowly (over the course of 10-20 years), with few therapeutic options other than lung transplantation⁽¹⁵⁾.


CONCLUSION

The correct diagnosis and classification of IIPs involves a broad multidisciplinary debate, with many gaps. Given the similarity of the clinical and pathological findings, together with the complexity of the differential diagnoses and the need for constant follow-up, high-resolution computed tomography plays a fundamental role in the diagnostic assessment of these diseases.


REFERENCES

1. Torres PPTS, Moreira MAR, Silva DGST, et al. High-resolution computed tomography and histopathological findings in hypersensitivity pneumonitis: a pictorial essay. Radiol Bras. 2016;49:112-6.

2. Mogami R, Goldenberg T, Marca PGC, et al. Pulmonary infection caused by Mycobacterium kansasii: findings on computed tomography of the chest. Radiol Bras. 2016;49:209-13.

3. Queiroz RM, Gomes MP, Valentin MVN. Pulmonary paracoccidioidomycosis showing reversed halo sign with nodular/coarse contour. Radiol Bras. 2016;49:59-60.

4. Koenigkam-Santos M, Cruvinel DL, Menezes MB, et al. Quantitative computed tomography analysis of the airways in patients with cystic fibrosis using automated software: correlation with spirometry in the evaluation of severity. Radiol Bras. 2016;49:351-7.

5. Bastos AL, Corrêa RA, Ferreira GA. Tomography patterns of lung disease in systemic sclerosis. Radiol Bras. 2016;49:316-21.

6. Francisco FAF, Rodrigues RS, Barreto MM, et al. Can chest high-resolution computed tomography findings diagnose pulmonary alveolar microlithiasis? Radiol Bras. 2015;48:205-10.

7. Alves UD, Lopes AJ, Maioli MCP, et al. Changes seen on computed tomography of the chest in mildly symptomatic adult patients with sickle cell disease. Radiol Bras. 2016;49:214-9.

8. Sverzellati N, Lynch DA, Hansell DM, et al. American Thoracic Society-European Respiratory Society classification of the idiopathic interstitial pneumonias: advances in knowledge since 2002. Radiographics. 2015;35:1849-71.

9. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733-48.

10. Mueller-Mang C, Grosse C, Schmid K, et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics. 2007;27:595-615.

11. Silva CIS, Jasinowodolinski D, Terra Filho M, et al. Atlas e diagnóstico diferencial: tomografia computadorizada de alta resolução do tórax - Jorge Kavakama. 1ª ed. Rio de Janeiro, RJ: Revinter; 2008.

12. Lynch DA, Travis WD, Müller NL, et al. Idiopathic interstitial pneumonias: CT features. Radiology. 2005;236:10-21.

13. Silva CIS, Müller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008;246:288-97.

14. Frankel SK, Cool CD, Lynch DA, et al. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004;126:2007-13.

15. Piciucchi S, Tomassetti S, Casoni G, et al. High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differential diagnosis. Respir Res. 2011;12:111.










Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InCor/HC-FMUSP), São Paulo, SP, Brazil

Correspondence:
Dr. Daniel Simões Oliveira
InCor/HC-FMUSP – Radiologia e Diagnóstico por Imagem
Avenida Doutor Enéas de Carvalho Aguiar, 44, Pinheiros
São Paulo, SP, Brazil, 05403-900
E-mail: danieloliveira8@live.com

Recebido para publicação em 27/July/2016
Aceito, após revisão, em 05/January/2017

Study conducted at the Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InCor/HC-FMUSP), São Paulo, SP, Brazil